search

Active clinical trials for "Cerebral Infarction"

Results 771-780 of 792

Telerobotic Ultrasound for Carotid Imaging - Feasibility Study

Carotid Artery DiseaseAtherosclerosis18 more

In this proposal, the investigators will demonstrate the feasibility and noninferiority of telerobotic ultrasonography as compared to traditional manual acquisition in performing a limited carotid Duplex examination and in carotid plaque detection.

Withdrawn11 enrollment criteria

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem...

Acute Ischemic StrokeMesenchymal Stem Cells5 more

The purpose of this study is to use an intravenous infusion of allogeneic human mesenchymal stem cells (Allo-hMSCs) to treat an acute ischemic stroke condition.

Temporarily not available37 enrollment criteria

The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With...

Intracranial AneurysmCerebral Ischemia

The first purpose of this study is to find out the clinical benefit and risk of oral aspirin for unruptured intracranial aneurysm (small than 7mm) combined with cerebral ischemia in patients in the real world. The second purpose of this study is to get the prediction model of aneurysm's rupture in patients who has unruptured intracranial aneurysm (small than 7mm) combined with cerebral ischemia , and find out who is suitable for oral aspirin.

Unknown status9 enrollment criteria

First-pass Recanalization With EmboTrap II in Acute Ischemic Stroke (FREE-AIS)

Acute Ischemic Stroke Due to Intracranial Large Artery Occlusion

This study is a prospective, open-label, multi-center, registry study, designed to to documents that EmboTrap II usage as a thrombectomy device for emergency large vessel occlusion (ELVO) in terms of the rate of First Pass Recanalization (FPR). Patients with ELVO will initially underwent mechanical thrombectomy usig EmboTrap II. FPR is defined as modified Tissue Thrombolysis In Cerebral Ischemia (mTICI) 2b or 3

Unknown status14 enrollment criteria

Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke...

Ischemic Stroke

Post-stroke cognitive impairment(PSCI) is one of the most important factors causing disabilities after stroke. Recent study found that gut microbiota plays a key role in neurological diseases. Two recent small sample studies reported gut dysbiosis in PSCI patients. In order to further verify the relationship between PSCI and gut microbiota and the predictive value of gut microbiota and serum markers for cognitive impairment and poor prognosis after ischemic stroke. The study intended to collect stool specimens of patients with acute ischemic stroke and assess their cognitive psychological state, and to establish a prospective multi-center follow-up cohort to explore the correlation between the dynamic changes of intestinal flora in patients with stroke and PSCI and poor prognosis of stroke.

Unknown status15 enrollment criteria

Characteristics of Blood- Brain Barrier Permeability in Neurological Patients

Traumatic Brain InjuryCerebral Infarction1 more

The main goal of the present study is to challenge the hypothesis that blood- brain barrier disruption following brain injury increases the risk for long-term disability, development of brain dysfunction, epileptic seizures and neuroanatomical alterations.

Unknown status8 enrollment criteria

Evaluation of the HARM for the Detection of a Cerebral Ischemia in TIA/TNA Patients

TIAStroke2 more

The research project investigates the incidence of the hyperintense acute reperfusion marker (HARM) in patients with transient ischemic attack (TIA) or transient neurological attack (TNA). Initially, HARM was described after acute ischemic stroke and is caused by a blood-brain barrier disorder after recanalization of an acute vessel occlusion and consecutive reperfusion. These result in a contrast agent extravasation into the subarachnoid space, which can be easily detected on fluid attenuated inversion recovery (FLAIR) images. TIA is defined as a transient focal neurological deficit with a probably cerebrovascular cause. In contrast, TNA is defined as a transient non-focal neurological deficit with multiple causes, including cerebrovascular. The clinical diagnosis of TIA is often flawed and the delineation of TIA and TNA can be difficult. MRI is the most important diagnostic method for the detection or exclusion of cerebral ischemia in patients with TIA/TNA in daily clinical practice. However, on diffusion-weighted imaging (DWI) approximately two-thirds of TIA cases and only one-fifth of TNA cases demonstrate acute cerebral ischemia. Supplementary perfusion-weighted imaging (PWI) scans can only slightly increase this percentage. The well-known HARM could prove to be complementary to DWI and PWI and close or at least reduce the existing gap. In the case of TNA in particular, this could be of clinical relevance in order to avoid mistreatment or even dismissal without further clarification after supposedly inconspicuous imaging. Therefore, the aim of this study is to record the incidence of HARM in a statistically significant number of cases of patients with TIA and TNA and to investigate relationships with symptom duration and anatomical localization. In addition, the dynamics of contrast enhancement in the subarachnoid space in TIA and TNA cases with HARM will be analyzed in detail.

Unknown status9 enrollment criteria

Predictive Factors of Outcome of Mechanical Thrombectomy After Acute Ischemic Stroke

Acute Ischemic Stroke

Predictive factors of outcome of mechanical thrombectomy after acute ischemic stroke

Unknown status8 enrollment criteria

Evaluation of IL-33 in Patients With the Acute Ischemic Stroke

Ischemic Stroke

Aim of the study is to evaluate the usefulness of interleukin 33 in the blood plasma in patients with the acute ischemic stroke of the brain in relation to mode of treatment (thrombolysis, thrombectomy, no treatment), risk factors in correlation with other inflammatory state markers (hsCRP, morphology with smear ). Blood is collected on the first and seventh days of stroke. The purpose is to clarify utility of IL 33 as a biomarker of acute stroke.

Unknown status8 enrollment criteria

Extracranial Carotid & Intracranial Arterial Stenosis in Ischemic Stroke

Ischemic StrokeCarotid Stenosis

The aim of the work is to; elucidate how the presence of carotid stenosis influence the pattern of stroke and also how it interact with other risk factors for stroke. Also identify predictors of intracranial stenosis and outcome in patients with carotid stenosis with or without intracranial stenosis.

Unknown status9 enrollment criteria
1...77787980

Need Help? Contact our team!


We'll reach out to this number within 24 hrs